{"id":"W2741056151","doi":"10.1158/1538-7445.am2017-2653","title":"Abstract 2653: The anti-myeloma activity of TTI-621 (SIRPαFc), a CD47-blocking immunotherapeutic, is enhanced when combined with a proteasome inhibitor","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"CD47; Cancer research; Bortezomib; Phagocytosis; Macrophage; Proteasome inhibitor; Immune system; Immunology; Multiple myeloma; Medicine; Biology; In vitro; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009727212,0.0003629607,0.0002895882,0.0001949319,0.0001052145,0.0001598945,0.0001327936,0.0002733811,0.002521274],"category_scores_gemma":[0.00005134199,0.00008968489,0.0002496894,0.0001687403,0.0001151181,0.00009772332,0.0001056239,0.000483593,0.000607356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001712639,"about_ca_system_score_gemma":0.0001970426,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000602742,"about_ca_topic_score_gemma":0.000561505,"domain_scores_codex":[0.9999233,0.00001089669,0.000005928664,0.00001065637,0.0000244065,0.00002473525],"domain_scores_gemma":[0.9999716,0.000004121758,0.000006714844,0.000002068135,0.000004137314,0.00001132567],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0008181015,0.00020975,0.0001246504,0.00008217375,0.0000142365,0.00008011273,0.00001013923,0.0001220523,0.9928377,0.00007013947,0.0003178917,0.005313106],"study_design_scores_gemma":[0.0001190815,0.002337344,0.002523675,0.000007232344,0.00002996294,0.0003434674,0.000008037927,0.0007608382,0.9904001,0.00001828676,0.003447995,0.000003776948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896733,0.00424422,0.00148732,0.000186562,0.0001306917,0.00006506845,0.0004500492,0.0001142357,0.003648623],"genre_scores_gemma":[0.9916376,0.001717544,0.001159114,0.0001037874,0.00003174709,0.00003881294,0.000845113,0.00001329612,0.004452984],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002521274,"threshold_uncertainty_score":0.008434534,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06647886095438363,"score_gpt":0.3651098816259278,"score_spread":0.2986310206715441,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}